Inpefa — Medical Mutual
Type 2 Diabetes to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit
Initial criteria
- Patient is age ≥ 18 years
- Patient has chronic kidney disease
- Patient has one or more cardiovascular risk factor(s), according to the prescriber
Reauthorization criteria
- Response to therapy is required for continuation of therapy unless otherwise noted
Approval duration
1 year